QUESTION: WHY THE HELL DOES A RUSSIAN DOCTOR HAVE TO TELL US THIS??
2 MINUTE VIDEO
https://www.bitchute.com/video/pqJhacfeW6nJ/
PING
sCiEnCe
In before the “millions of people have had the vaccines with no problems” types.
To which I reply: Yet.
Thank you for posting!
📌
In before the Free Republic Vax Pimps.
NY Times via google, for Covid-19:
“Sep 21, 2021 Deaths:2,366 7-day avg:2,046”
The risk/reward ratio greatly favors the Covid vaccines for indicated use in adults 25 years of age and up.
The Covid vaccines have a very high side effect problem, but it is far, far less than the Covid-19 infection problem.
📌
“An analysis of data in Israel, which has one of the world’s highest Covid-19 vaccination levels, showed almost 60% of those hospitalized for Covid were fully vaccinated.”
78% vaccinated, making up 59% of the hospitalizations
That still favors the vaccinated by about a two-to-one ratio.
Countermeasures Injury Compensation Program (CICP) Data
Aggregate Data as of September 1, 2021
[My somewhat hasty selection follows:]
Convalescent Plasma Death 3
Convalescent Plasma / Remdesivir Death 3
COVID-19 Medications Death 10
COVID-19 Vaccine Bell’s Palsy 20
COVID-19 Vaccine Blood Clots 30
COVID-19 Vaccine Bursitis 3
COVID-19 Vaccine Death 44
COVID-19 Vaccine Death / GBS 2
COVID-19 Vaccine Deep Vein Thrombosis (DVT) 6
COVID-19 Vaccine Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE) 5
COVID-19 Vaccine Guillain-Barrè Syndrome (GBS) 20
COVID-19 Vaccine Myasthenia Gravis Disease 2
COVID-19 Vaccine Myocarditis 11
COVID-19 Vaccine Paralysis 6
COVID-19 Vaccine Parsonage Turner Syndrome (PTS) 3 (pain in shoulder, then severe weakness)
COVID-19 Vaccine Pericarditis 12
COVID-19 Vaccine Pulmonary Embolism 14
COVID-19 Vaccine Seizures 10
COVID-19 Vaccine Severe Allergic Reaction 12
COVID-19 Vaccine Tachycardia 5
COVID-19 Vaccine Unable to Breathe / Unresponsive 1
COVID-19 Vaccine Unable to Walk 1
COVID-19 Vaccine Unresponsive / Foaming at Mouth / Low Blood Pressure 1
COVID-19 Vaccine Unresponsive / Tachycardia / Low Heart Rate / Pain 1
COVID-19 Vaccine Vestibular Neuritis 3
Hydroxychloroquine Death 19
Remdesivir Death 27
Ventilator Death 135
Ventilator / Covid-19 Medications Death 330
Ventilator / Hydroxychloroquine Death 22
Ventilator / Hydroxychloroquine / Azithromycin Death 50
Total Filed 2,392
https://www.hrsa.gov/cicp/cicp-data
CICP claims are generally only made in cases where the side effects are severe and long lasting.
Since the cause is not always clear, actual severe cases may be several times higher.
It takes time to justify and file a claim, so claim counts lag actual injuries.
Shortness of breath
Chest pain
Vomiting or persistent abdominal pain
Blurred vision or pain in the eyes
Severe or persistent headache
Weakness in any body part
Seizures
Pain in limbs or swelling in arms or feet
This is the German version of Schwerwiegende unerwünschte Reaktionen:
“Verdachtsfälle von Nebenwirkungen und Impfkomplikationen
nach Impfung zum Schutz vor COVID-19 seit Beginn der
Impfkampagne am 27.12.2020 bis zum 31.07.2021”
https://www.pei.de/SharedDocs/Downloads/DE/newsroom/dossiers/sicherheitsberichte/sicherheitsbericht-27-12-bis-31-07-21.pdf?__blob=publicationFile&v=4
“In 1.254 Verdachtsfallmeldungen wurde über einen tödlichen Ausgang in unterschiedlichem zeitlichem Abstand zur Impfung berichtet. In 48 Fällen hält das Paul-Ehrlich-Institut einen ursächlichen Zusammenhang mit der jeweiligen COVID19-Impfung für möglich oder wahrscheinlich. Das Paul-Ehrlich-Institut hat 31 Fälle einer Thrombose mit Thrombozytopenie und sieben Fälle einer Thrombozytopenie/idiopathischen thrombozytopenischen Purpura (ITP) mit tödlichem Ausgang nach Vaxzevria bzw. COVID-19-Impfstoff Janssen gemäß den....”
I think that means they believe 48 people died from the vaccines in Germany, which has I think about 70% of adults vaccinated against Covid.
https://de.wikipedia.org/wiki/SARS-CoV-2-Impfstoff
“Bell’s palsy is a type of facial paralysis that results in a temporary inability to control the facial muscles on the affected side of the face.”
“Bell’s palsy is the most common cause of one-sided facial nerve paralysis (70%). It occurs in 1 to 4 per 10,000 people per year. About 1.5% of people are affected at some point in their lives.”
https://en.wikipedia.org/wiki/Bell%27s_palsy
“After a follow-up of at least one year or until restoration, complete recovery had occurred in more than two-thirds (71%) of all patients. Recovery was judged moderate in 12% and poor in only 4% of patients.”
“Guillain-Barré syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks part of its peripheral nervous system—the network of nerves located outside of the brain and spinal cord. GBS can range from a very mild case with brief weakness to nearly devastating paralysis, leaving the person unable to breathe independently. Fortunately, most people eventually recover from even the most severe cases of GBS. After recovery, some people will continue to have some degree of weakness.
“Guillain-Barré syndrome can affect anyone. It can strike at any age (although it is more frequent in adults and older people) and both sexes are equally prone to the disorder. GBS is estimated to affect about one person in 100,000 each year.”
Canadian info:
Myocarditis is inflammation of the heart muscle and pericarditis is inflammation of the lining around the heart.
Up to and including September 10, 2021, there were 718 confirmed reports of myocarditis/pericarditis that met Level 1 to 4 of Brighton Collaboration level of diagnostic certainty. Of the myocarditis/pericarditis reports:
408 reports followed vaccination with a Pfizer-BioNTech Comirnaty COVID-19 vaccine, 290 followed vaccination with a Moderna Spikevax COVID-19 vaccine, 18 followed vaccination with an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine, and the vaccine name of two were unspecified
Among the 408 reports of myocarditis/pericarditis following Pfizer-BioNTech Comirnaty COVID-19 vaccine (administered to those 12 years of age and older):
Symptoms started between 5 minutes and 94 days after vaccination
Median age is 29 years (age range 12 to 87 years old)
258 were males [median age 23 years (age range 12 to 82 years old)], 146 were females [median age 39 years (age range 12 to 87 years old)], and the sex of four were unspecified
176 reports following the first vaccine dose, 183 reports following the second vaccine dose, and the dose number for 49 were not specified
Current analyses show the number of reports of myocarditis/pericarditis following the Pfizer-BioNTech Comirnaty COVID-19 vaccine is higher than what would be expected in the general population of males and females less than 30 years old and following the second dose.
Among the 290 reports of myocarditis following vaccination with a Moderna Spikevax COVID-19 vaccine (administered to those 12 years of age and older):
Symptoms started between 14 minutes and 69 days after vaccination
Median age is 28 years (age range 18 to 95 years old)
211 were males [median age 26 years (age range 18 to 95 years old)], 75 were females [median age 35 years (age range 18 to 76)], the sex of one was ‘other’, and the sex of three were unspecified
59 reports following the first vaccine dose, 199 reports following the second vaccine dose, and the dose number for 32 were unspecified
Current analyses show the number of reports of myocarditis/pericarditis following the Moderna Spikevax COVID-19 vaccine is higher than what would be expected in the general population, particulary among males and females less than 40 years old and following the second dose.
Evidence is evolving and investigations into the association between myocarditis/pericarditis and mRNA vaccines continue.
https://health-infobase.canada.ca/covid-19/vaccine-safety/#detailedSafetySignals
Also from Canada:
Up to and including September 10, 2021, there are a total of 76 reports of GBS that met Level 1 to 4 of Brighton Collaboration level diagnostic certainty.. Of the GBS reports:
30 reports followed vaccination with an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine, 31 followed vaccination with a Pfizer-BioNTech Comirnaty COVID-19 vaccine, and 15 followed vaccination with a Moderna Spikevax COVID-19 vaccine.
Current results show the rate of GBS following AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccination is higher than the rate of GBS following Pfizer-BioNTech Comirnaty COVID-19 vaccine or Moderna Spikevax COVID-19 vaccine. As well, the number of reports of GBS following AstraZeneca Vaxzevria/COVISHIELD vaccination are higher than would normally be expected in the general population.
Among the 30 reports of GBS following an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine:
Symptoms started between 6 hours and 25 days after vaccination
Median age is 55 years (age range 40 to 77 years old)
22 were males [median age 55 years (age range 40 to 66 years old)], 7 were females [median age 51 years (age range 40 to 77 years old)], and the age and sex of one was unspecified
21 reports following the first vaccine dose, and the dose number for 9 were unspecified
https://health-infobase.canada.ca/covid-19/vaccine-safety/#detailedSafetySignals
Thrombosis with thrombocytopenia syndrome (TTS) is characterized as blood clotting with low platelet levels.
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT), also known as Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT), is characterized as TTS that seems to be vaccine-induced due to the laboratory-confirmed presence of platelet factor (PF) 4 antibodies.
Up to and including September 10, 2021, there were 81 reports of TTS that met Level 1 to 4 of Brighton Collaboration level of diagnostic certainty. Of the TTS reports:
61 reports followed vaccination with an AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine, 16 followed vaccination with a Pfizer-BioNTech Comirnaty COVID-19 vaccine, and four followed vaccination with a Moderna Spikevax COVID-19 vaccine.
Of the 61 TTS reports following a AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine:
Symptoms started between 1 and 37 days after vaccination.
Median age is 57 years (age range 19 to 88 years old)
32 were males [median age 57 years (age range 34 to 73 years old)], 28 were females [median age 56 years (age range 19 to 88 years old)], and the age and sex of one was not specified.
55 reports following the first vaccine dose, and the dose number for six were not specified
38 had laboratory results showing the presence of platelet factor (PF) 4 antibodies, indicating VITT (also known as VIPIT).
Six people died.
https://health-infobase.canada.ca/covid-19/vaccine-safety/#detailedSafetySignals
Canada has about 38 million people and is about 70% vaccinated against Covid.
Pfizer ~43 million doses distributed
Moderna ~18 million doses distributed
AstraZeneca ~3 million doses distributed
“Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Pfizer-BioNTech COVID-19 Vaccine”
“Reports of lymphadenopathy were imbalanced with 58 more cases in the vaccine group (64) than the placebo group (6); lymphadenopathy is plausibly related to the vaccine. Lymphadenopathy occurred in the arm and neck region and was reported within 2 to 4 days after vaccination. The average duration of lymphadenopathy was approximately 10 days. Bell’s palsy was reported by four vaccine recipients and none of the placebo recipients.”
“The most common serious adverse events in the vaccine group which were numerically higher than in the placebo group were appendicitis (7 in vaccine vs 2 in placebo), acute myocardial infarction (3 vs 0), and cerebrovascular accident (3 vs 1).”
https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html
Those comments I believe are for less than 2000 patients.
Severe redness(>10cm) in 3 out of 1802 55+ patients.
“The Moderna COVID-19 Vaccine’s Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events”
“Reports of lymphadenopathy were imbalanced with 1.1 % of persons in the vaccine group and 0.6% in the placebo group reporting such events; lymphadenopathy is plausibly related to the vaccine. Lymphadenopathy occurred in the arm and neck region and was reported within 2 to 4 days after vaccination. The median duration of lymphadenopathy was 1 to 2 days. Bell’s palsy was reported by three vaccine recipients and one placebo recipient. One case of Bell’s palsy in the vaccine group was considered a serious adverse event.”
“The most common serious adverse events occurring at higher rates in the vaccine group than the placebo group were myocardial infarction (5 cases in vaccine group vs. 3 cases in placebo group), cholecystitis (3 vs. 0), and nephrolithiasis (3 vs. 0).”
https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html
Those comments I believe are for less than 3800 patients.
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year
Recruiting
Sinai Hospital
Baltimore, Maryland, United States, 21215
https://clinicaltrials.gov/ct2/show/NCT04910971